DCEG Seminar on the Fourth Edition of Cancer Epidemiology and Prevention
, by DCEG Staff
From left to right, back row: Annelie Landgren, James Cerhan, Michael Thun, Stephen Chanock, Michael Dean; front row: Martha Linet, David Schottenfeld
On June 6, 2018, DCEG hosted a half-day session with several editors and contributors to the fourth edition of Cancer Epidemiology and Prevention, published by Oxford University Press in November 2017.
Lead editor Dr. Michael Thun, American Cancer Society (retired), gave a keynote lecture on “Future directions in cancer epidemiology and prevention: Learning from the research of the past decade,” in which he highlighted the implications of epidemiologic and genetic research for cancer control, prevention, treatment, and survivorship. Other panel speakers included:
- Martha Linet, M.D., M.P.H. (co-editor), “Future Directions in Cancer Epidemiology: Life-course Assessment, Low-Dose Exposures, and Tumor Classification”
- Dr. James Cerhan, Mayo Clinic (co-editor), “Future Directions in Cancer Epidemiology: Regulation of the Genome, Tumor Microenvironment and Host Immune Response”
- Dr. David Schottenfeld, University of Michigan (retired) (co-editor), “Human Intestinal Microbiome: Future Research Directions on Mechanisms for Obesity, Neoplasia and Immune-mediated Diseases”
- Michael Dean, Ph.D. (contributor), “Genetics and Genomics in the Study of Cancer Etiology, Mechanisms of Neoplasia, and Applications to Prevention and Therapy”
- Mitchell Gail, M.D., Ph.D. (contributor), “Cancer Risk Models and Prospects for Prevention”
The new edition features in-depth updates on cancer incidence, mortality, and survival trends; known and suspected causes of cancer; comprehensive assessment of the epidemiology of specific cancer outcomes; and implications of the rapidly growing knowledge about etiology for cancer prevention.